AGNELLI, Giancarlo
 Distribuzione geografica
Continente #
NA - Nord America 16.773
EU - Europa 12.091
AS - Asia 11.231
SA - Sud America 2.206
AF - Africa 301
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 15
Totale 42.635
Nazione #
US - Stati Uniti d'America 16.429
SG - Singapore 5.558
UA - Ucraina 2.210
IE - Irlanda 2.156
RU - Federazione Russa 1.860
BR - Brasile 1.696
IT - Italia 1.559
CN - Cina 1.439
HK - Hong Kong 1.293
VN - Vietnam 1.244
SE - Svezia 962
DE - Germania 889
FR - Francia 719
FI - Finlandia 678
GB - Regno Unito 409
KR - Corea 286
IN - India 266
TR - Turchia 240
CA - Canada 159
AR - Argentina 158
BD - Bangladesh 144
IQ - Iraq 129
MX - Messico 110
AT - Austria 103
PL - Polonia 100
PK - Pakistan 90
EC - Ecuador 83
ZA - Sudafrica 81
CH - Svizzera 78
NL - Olanda 78
UZ - Uzbekistan 74
CO - Colombia 68
VE - Venezuela 67
JP - Giappone 65
SA - Arabia Saudita 57
ES - Italia 54
BE - Belgio 52
CL - Cile 49
ID - Indonesia 49
LB - Libano 46
PH - Filippine 41
MA - Marocco 40
TN - Tunisia 36
CZ - Repubblica Ceca 35
EG - Egitto 35
LT - Lituania 35
JO - Giordania 31
KE - Kenya 29
GR - Grecia 28
PY - Paraguay 27
MY - Malesia 20
BO - Bolivia 19
AE - Emirati Arabi Uniti 18
UY - Uruguay 18
CR - Costa Rica 16
PE - Perù 16
JM - Giamaica 15
KG - Kirghizistan 15
OM - Oman 14
AZ - Azerbaigian 13
IL - Israele 13
AL - Albania 12
DZ - Algeria 12
PA - Panama 12
PS - Palestinian Territory 12
RO - Romania 12
SK - Slovacchia (Repubblica Slovacca) 11
TH - Thailandia 11
ET - Etiopia 10
EU - Europa 10
NG - Nigeria 10
BG - Bulgaria 9
KZ - Kazakistan 9
NP - Nepal 9
HR - Croazia 7
SY - Repubblica araba siriana 7
AU - Australia 6
BH - Bahrain 6
CI - Costa d'Avorio 6
EE - Estonia 6
KW - Kuwait 6
NZ - Nuova Zelanda 6
SN - Senegal 6
XK - ???statistics.table.value.countryCode.XK??? 6
AO - Angola 5
GE - Georgia 5
GY - Guiana 5
LY - Libia 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
KH - Cambogia 4
NI - Nicaragua 4
GA - Gabon 3
HN - Honduras 3
QA - Qatar 3
ZW - Zimbabwe 3
Totale 42.568
Città #
Singapore 3.827
Chandler 2.342
Dublin 2.146
Hong Kong 1.285
San Mateo 1.222
San Jose 1.173
Jacksonville 1.134
Ashburn 941
Boardman 749
Dong Ket 681
Santa Clara 679
Altamura 671
Moscow 645
Medford 581
Princeton 575
Lauterbourg 516
Lawrence 501
Des Moines 494
Wilmington 396
Ann Arbor 383
Andover 360
Perugia 356
Seoul 284
Beijing 278
Los Angeles 224
Munich 219
Ho Chi Minh City 200
The Dalles 196
Saint Petersburg 174
New York 164
São Paulo 158
Izmir 146
Helsinki 139
Hanoi 137
Piscataway 123
Norwalk 112
Shanghai 94
San Paolo di Civitate 93
Frankfurt am Main 79
Redmond 66
Turku 66
Tokyo 61
Chicago 60
Dallas 60
Rome 60
Brooklyn 59
Nuremberg 59
Orem 58
Warsaw 54
Rio de Janeiro 53
Brussels 51
Montreal 50
Baghdad 49
Chennai 49
Houston 47
Stockholm 46
Johannesburg 44
Atlanta 41
Belo Horizonte 40
Boston 40
Ottawa 40
Lahore 39
London 39
Woodbridge 39
Columbus 37
Denver 36
Falls Church 36
Dearborn 35
Brasília 34
Hefei 32
Amsterdam 31
San Francisco 31
Manchester 30
Phoenix 30
Seattle 30
Mexico City 29
Redwood City 29
Tashkent 29
Jeddah 28
Vienna 28
Amman 27
Mumbai 27
Toronto 27
Da Nang 26
New Delhi 26
Ankara 25
Council Bluffs 25
Den Haag 25
Guangzhou 25
Poplar 25
Nairobi 24
Guayaquil 23
Medellín 21
Philadelphia 21
Auburn Hills 20
Caracas 20
Charlotte 20
Dhaka 20
Falkenstein 20
Istanbul 20
Totale 26.719
Nome #
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 148
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 142
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 140
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 139
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 133
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome. 133
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS Project 133
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 133
Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case-control study 128
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 128
Acute stroke symptoms: Do differences exist between sexes? 127
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 125
Aspirin for preventing the recurrence of venous thromboembolism. 124
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 124
Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis 123
Epidemiology of cerebral vein and sinus thrombosis. 121
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 120
[Spinal anesthesia and prophylaxis of venous thromboembolism. Results of a national survey]. 117
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 117
Early admission to stroke unit influences clinical outcome 115
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study 115
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 114
Severity of acute intracerebral haemorrhage, elderly age and atrial fibrillation: Independent predictors of poor outcome at three months 114
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. 113
Secondary stroke prevention in women. 113
A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery The @RISTOS Project 111
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 109
Chemotherapy-associatedthromboembolic risk in cancer outpatients and effect of nadroparinthromboprophylaxis: results of a retrospective analysis of the PROTECHT study. 108
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. 108
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 107
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 107
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients with Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 107
A prospective study on cardiovascular events after acute pulmonary embolism 106
[Effect of platelet-derived growth factor on the in vitro cell proliferation of chick embryo skin]. 106
Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. 106
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 106
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 106
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 106
A sudden neurological deficit in a patient with endocarditis. 105
Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. 105
Cancer-associated ischemic stroke: A retrospective multicentre cohort study 105
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 105
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 105
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 105
Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter related deep vein thrombosis in a child with acute lymphoblastic leukemia 104
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. 104
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 104
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome. 104
Acute pulmonary embolism: external validation of an integrated risk stratification model. 104
A new strategy for anticoagulation: The factor XI inhibitors 103
Gene-drug interaction in stroke. 103
Risk factors for venous thromboembolism in the elderly: results of the master registry. 103
[Acute immunoallergic thrombopenia due to sulfamethoxazole-trimethoprim]. 103
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 103
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 103
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients 102
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. 102
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 102
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 102
Lessons learned from the global orthopaedic registry: study design, current practice patterns, and future directions. 101
Initial treatment of venous thromboembolism 101
Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. 101
Prevention of venous thromboembolism in surgical patients 100
Arterite temporale occulta: contributo casistico e revisione della letteratura 100
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. 100
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 100
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 100
Risk factors for adverse short-term outcome in patients with pulmonary embolism 99
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 99
Isolated monoparesis following stroke 99
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 99
The good use of plasma. A critical analysis of five international guidelines. 99
Cardiac hemangioma of the right atrium: a possible cause of cerebellar stroke. 99
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 99
Lacunar stroke syndromes as predictors of lacunar and non-lacunar infarcts on neuroimaging: a hospital-based study 99
Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study. 98
Acute pulmonary embolism. 98
D-dimer for riskstratification in patients with acute pulmonary embolism. 98
[Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism]. 98
Risk Profile of Symptomatic Lacunar Stroke Versus Nonlobar Intracerebral Hemorrhage 98
Clinical skills or high-tech MR in TIA patients: what makes the difference? 98
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 98
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis 98
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 97
Acute pulmonary embolism: risk stratification in the emergency department. 97
A prospective study on survival in cancer patients with and without venous thromboembolism. 97
Vascular cognitive impairment: a pragmatic concept 96
Risk factor for upper limb deep vein thrombosis 96
Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism 96
Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. 96
[Determinants of prognosis in acute pulmonary embolism: the role of serum troponins]. 96
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. 96
Cervical artery dissection: emerging risk factors. 96
Profilassi della trombosi venosa profonda in neurochirurgia 95
Cryptogenic stroke: time to determine aetiology. 95
[Prevention of venous thromboembolism in orthopedic surgery and traumatology]. 95
A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits. 95
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 95
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 94
Non-neurological complications of acute stroke: frequency and influence onclinical outcome. 94
Totale 10.713
Categoria #
all - tutte 200.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 200.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.162 0 0 0 0 0 0 0 0 0 96 334 732
2021/20224.446 53 780 64 153 232 31 46 1.540 68 167 469 843
2022/20238.339 663 1.638 121 542 651 1.170 21 340 2.832 23 264 74
2023/20242.458 205 309 189 40 47 22 475 123 164 119 427 338
2024/20256.653 52 714 151 240 924 326 179 510 1.438 429 1.052 638
2025/202613.563 1.217 868 729 1.822 1.870 1.244 2.582 741 1.472 1.018 0 0
Totale 43.652